A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them

and out of school (in conjunction with CCDPHP); conducting projects to implement and evaluate means
to prevent perinatal transmission of HIV infection;
supporting risk-reduction efforts within the national
hemophilia comprehensive care program; supporting
a joint plan to provide HIV/STD/TB-prevention activities in drug treatment centers; collaborating with
state and local agencies to implement model plans
for state dental health programs; collaborating with
HRSA to evaluate comprehensive AIDS/HIV prevention services, early diagnosis, and clinical treatment in community health centers as a means of
preventing HIV transmission; evaluating effectiveness of street outreach programs; evaluating the
impact of HIV counseling and testing on behavior
change among clients at drug treatment centers and
STD clinics; assessing effectiveness of partner
notification in identifying high-risk patterns of HIVinfected persons; evaluating the impact of preventive
therapy programs on reducing TB morbidity and
mortality among HIV-infected persons; developing
a computerized decision analysis model that will help
assess the potential effectiveness and cost benefit of
prevention interventions; and conducting HIV community demonstration projects to evaluate HIVprevention interventions, with particular emphasis on
serving hard-to-reach groups.
Goal 3-related programs center around developing
prevention technologies and promoting scientific
knowledge in public policy and public health practice, including: developing and testing strategies to
modify high-risk behaviors and sustain low-risk
behaviors, and assessing effectiveness of interventions in controlled trials across different populations;
implementing pilot projects in community health
centers, in coordination with HRSA, to evaluate
effectiveness of providing risk-reduction counseling,
HIV counseling and testing, primary medical care,
and preventative/curative therapy for persons at risk
for HIV infection and their sex/needle-sharing partners and family members; conducting research in
development and evaluation of new diagnostic tests
for TB; conducting TB/HIV demonstration studies
to assess efficacy of tuberculosis preventive therapy
and risk of TB and AIDS in persons infected with
TB and HIV; developing model curriculum guidelines on infection control for the dental profession;
developing guidelines for management of occupational exposures to HIV (in conjunction with NIOSH
and CID); developing guidelines to protect healthcare workers from TB while treating AIDS patients
(in conjunction with NIOSH and CID); revising
guidelines for counseling and testing in health-care
facilities (in conjunction with CID and PHPPO);

developing risk-assessment guidelines for people at

high or low risk of HIV infection (in conjunction with
NAIEP); developing evaluation guidelines and providing technical assistance for community- and
individual-level behavioral HIV-prevention interventions (in conjunction with NAIEP); supporting special
projects to educate dental care providers regarding
infection control and other issues relevant to HIV
prevention; and developing an HIV-prevention program informational interchange among public health
workers.
CPS activities related to Goal 4 strive to strengthen
local, state, national and international prevention
capacities to confront the epidemic, including: providing start-up funds and technical assistance to
minority CBOs through cooperative agreement with
the U.S. Conference of Mayors; collaborating with
state and local HIV-prevention programs to train
health-care workers to counsel persons who are
tested for HIV antibodies; promoting joint planning,
collaboration, and technical assistance among health
departments, minority community leadership, and
minority and other CBOs (in conjunction with
NAIEP); collaborating with national and regional
minority organizations to provide their constituent
CBOs with technical assistance in implementing and
evaluating HIV prevention programs (in conjunction
with CCDPHP and NAIEP); sponsoring or co-sponsoring national and regional workshops and conferences to encourage the exchange information and
planning of appropriate strategies for future efforts;
providing technical support to the U.S. Agency for
International Development (USAID) for HIV projects
(in conjunction with IHPO, CCDPHP, and CID); providing scientific, managerial, and technical assistance
to the World Health Organization (WHO), Pan
American Health Organization (PAHO), other countries, and other international organizations; developing and conducting an international course in applied
epidemiology of AIDS/HIV (in conjunction with CID,
PHPPO, and NAIEP); collaborating at multilateral
and bilateral levels to strengthen national STDcontrol programs which will concurrently advance efforts to prevent the spread of HIV infection (in conjunction with IHPO); and sponsoring or co-sponsoring
international workshops and conferences with multilateral/bilateral agencies to exchange information and
plan appropriate strategies for future efforts.
CSP FY '91 Extramural HIV Funding
Approximately 89% of the CSP HIV FY '91 budget
will be spent extramurally. Examples of CPS-funded
programs include:

1. HIV Prevention Funding

48

Reproduction By Permission Only

~1991 ASAP

Rerduto ByC Pemsso Ony~91AA